Nrf2 agonists ameliorate anemia of inflammation by disrupting the hepcidin-ferroportin axis Feb. 18, 2022
For pain signaling, endocytosis is not the end Feb. 9, 2022 By Anette Breindl Researchers at New York University have demonstrated that protease-activated receptor 2 (PAR2) on epithelial cells of the colon continued after they were trafficked from the cell membrane.Read More
RSS
